This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Scott Danzis
Scott D. Danzis
Washington +1 202 662 5209 Download V-card

Scott Danzis is a partner in the firm’s Food & Drug and Health Care practice groups.  His practice focuses primarily on the regulation of medical devices, but also includes regulation of drugs, biologics, and tobacco products.  Mr. Danzis regularly works with companies in developing strategies for interacting with the U.S. Food and Drug Administration (FDA), including strategies for clinical development and premarket review (including appeals and dispute resolution, when needed).  He also advises on compliance with postmarket requirements, including advertising and promotion restrictions, quality system and manufacturing requirements, postmarket reporting, recalls, and enforcement actions.

Previous Experience

  • U.S. Food and Drug Administration, Office of the Chief Counsel
  • U.S. Department of Health and Human Services, Agency for Health Care Policy and Research
  • The Best Lawyers in America, FDA (2011-2018)
  • Legal 500 US, M&A: Commercial Deals and Contracts (2016-2017)
  • Washington DC Super Lawyers, FDA (2013-2017)